Research | Hadassah International

Hadassah International Supports the Hadassah Medical Center: More than a Hospital!

Hadassah-Developed Imaging Agent to Begin Clinical Trials with Multi-million Euro Grant

The Hadassah Medical Organization has been awarded a €3.69 million ($4 million) grant from the European Union (EU) to begin clinical trials with its Hadassah-developed innovative radioactive imaging substance that…

Media Coverage of Hadassah’s Successful ALS Trials and Treatment Protocol

Stem Cell Treatment Inhibits ALS Disease Progression In 87% of Patients, according to clinical trial conducted by HMO and BrainStorm Cell Therapeutics

Successful Trial Drug Helps Patient with ALS

Stroke Research

EAT RIGHT TO PREVENT STROKES

Hadassah Hospital

STROKE PREVENTION, TOO

Israeli specialists recommend that bearers of the “breast cancer gene” have their Ovaries removed at a young age

Hadassah Opens Clinic for Cardiac Genetic Counseling and Treatment

Hadassah Drug to Fight Fatty Liver Disease Progressing Well in US Clinical Trials

Hadassah Cardiologist is Key Researcher in Identifying Genetic Heart Mutation

Macular Degeneration

First Patient Receives Stem Cell-based Therapy for Macular Degeneration at Hadassah

Hadassah Brain Mapping Has Important Implications for Early Alzheimer’s Diagnosis

Drugs and Antibiotics

Hadassah-Developed Autoimmune Disease Drug Proves Safe in Phase I Clinical Trial

Stroke Research

Stem Cells and Platelets: Hadassah Pioneers Stroke Strategy

Researchers at Hadassah Stop the Progression of Amyotrophic Lateral Sclerosis (ALS)

Hadassah Conducts Unprecedented Trial of Stem Cell Treatment for MS

Hadassah UK climb the Three Peaks in 24 Hours

Bone Marrow Registry

Hadassah’s Bone Marrow Transplantation Department Receives Prestigious Recognition

International Connections

Hadassah Collaborates with Columbia University to Identify Treatment for Alopecia